Roche Advances Alzheimer’s Blood Tests with Promising New Data
Roche has unveiled fresh data supporting two of its innovative blood tests, designed to assist in diagnosing Alzheimer’s disease with ...
Tag: Biotech
Compass Pathways Delays Key Phase 3 Data for Psilocybin Therapy, Cuts 30% of Workforce
Compass Pathways, a leading player in psychedelic-based mental health treatments, has announced a significant delay in the release of data ...
Ventus Therapeutics Advances Daily Oral Lupus Treatment with Promising Phase 1 Results
In a lupus treatment market set for rapid transformation, Ventus Therapeutics is preparing to break new ground with its investigational ...
Novartis Faces Setback with MorphoSys Acquisition as Safety Concerns Delay Key Drug Approval Plans
In a turn of events that could reshape Novartis' $2.9 billion acquisition of German biotech MorphoSys, the Swiss pharmaceutical giant ...
